Effect of statins on C-reactive protein in patients with coronary artery disease
Generate an AI Snapshot to get a quick, structured summary of this paper.
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
The view that the autoimmune response in LEMS retards tumour growth and the recognition of LEMS in any patients with SCLC could have important implications for long-term outcome after antitumour therapy is supported.
Abstract
In addition to their lipid-lowering effects, HMG CoA-reductase inhibitors (statins) have anti-inflammatory properties, 1 Rosenson RS Tangney CC Antiatherothrombotic properties of statins: implications for cardiovascular event reduction. JAMA. 1998; 279: 1643-1650 Crossref PubMed Scopus (976) Google Scholar so they should lower serum C-reactive protein (CRP), a sensitive marker of inflammation. We explored this possibility in hyperlipidaemic coronary patients.